Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of single donor platelets

S A Kirkley1, N Blumberg

  • 1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, NY 14642.

Blood Reviews
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haem is associated with thrombosis in neonates and infants undergoing cardiac surgery for congenital heart disease.

Vox sanguinis·2017
Same author

Maresin 1 induces a novel pro-resolving phenotype in human platelets.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Skeletal injuries sustained during the Haiti earthquake of 2010: a radiographic analysis of the casualties admitted to the Israel Defense Forces field hospital.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2016
Same author

Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.

Vox sanguinis·2015
Same author

ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion.

Vox sanguinis·2015
Same author

A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling.

Journal of thrombosis and haemostasis : JTH·2012

Single donor platelets offer potential benefits like reduced alloimmunization, but widespread adoption faces challenges. Current evidence lacks consensus on outweighing risks, setup difficulties, and costs for routine use.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Immunology

Background:

  • Apheresis technology advancements have increased the availability of single donor platelets.
  • Hypothesized benefits include reduced disease transmission, alloimmunization, and improved platelet function and storage.
  • A shift towards routine single donor platelet transfusions is being considered by some.

Purpose of the Study:

  • To evaluate the purported advantages of single donor platelets.
  • To assess the consensus regarding the routine use of single donor platelets in blood banks.
  • To weigh the benefits against the risks, logistical challenges, and financial implications.

Main Methods:

  • Review of current literature on apheresis technology and platelet transfusion components.

Related Experiment Videos

  • Analysis of hypothesized benefits versus established risks and practical considerations.
  • Discussion of donor safety, program implementation, and cost-effectiveness.

    • Main Results:

    • While single donor platelets facilitate HLA compatibility selection, a consensus on routine use is lacking.
    • Potential benefits like reduced alloimmunization are supported by some evidence.
    • Significant concerns remain regarding donor risks, program setup complexities, and overall expenses.

    Conclusions:

    • The widespread adoption of single donor platelets as a routine component is not yet merited.
    • Further research and consensus-building are needed to balance benefits against practical and economic challenges.
    • Facilitating HLA compatibility is a key advantage, but not sufficient for universal implementation.